An Herbal Hope: Is XBJ A Game-Changer in Sepsis Management?
RebelEM
AUGUST 14, 2023
This varies from the 2001 definition, which used SIRS criteria and was thought to overly focus on inflammation. Secondary Outcome Results: ICU mortality: placebo 20.0% The primary outcome was patient oriented. Many of the secondary outcomes were changed well after most of the data was acquired. vs. XBJ 14.4%
Let's personalize your content